Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group-Reference-Cited by-同舟云学术

Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group

Published:2016-06 Issue:3 Volume:141 Page:447-453
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Harano Kenichi,Hirakawa Akihiro,Yunokawa Mayu,Nakamura Toshiaki,Satoh Toyomi,Nishikawa Tadaaki,Aoki Daisuke,Ito Kimihiko,Ito Kiyoshi,Nakanishi Toru,Susumu Nobuyuki,Takehara Kazuhiro,Watanabe Yoh,Watari Hidemichi,Saito Toshiaki

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference16 articles.

1. Clinical features and outcomes of uterine and ovarian carcinosarcoma;Jonson;Gynecol. Oncol.,2006

2. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior;Bansal;Obstet. Gynecol.,2008

3. The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): a critical literature review;Vorgias;Arch. Gynecol. Obstet.,2010

4. The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus;Park;Ann. Surg. Oncol.,2010

5. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis;Nemani;Gynecol. Oncol.,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival;Cancers;2023-02-25

2. The prognostic significance of the heterologous component in uterine carcinosarcomas;Revista da Associação Médica Brasileira;2023

3. Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26);Gynecologic Oncology;2022-12

4. Beyond Serous: Treatment Options for Rare Endometrial Cancers;Current Treatment Options in Oncology;2022-10-07

5. Adjuvant therapy and prognosis in uterine carcinosarcoma;Journal of the Formosan Medical Association;2021-11